D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 67 Citations 16,608 172 World Ranking 5215 National Ranking 2523

Overview

What is she best known for?

The fields of study she is best known for:

  • Enzyme
  • Cancer
  • Apoptosis

Sarah J. Parsons mainly focuses on Cancer research, Proto-oncogene tyrosine-protein kinase Src, Tyrosine kinase, Receptor tyrosine kinase and Growth factor receptor. The Cancer research study combines topics in areas such as Receptor, Internal medicine, STAT protein and Endocrinology. Phosphorylation covers Sarah J. Parsons research in Proto-oncogene tyrosine-protein kinase Src.

Her research investigates the connection between Tyrosine kinase and topics such as Kinase that intersect with problems in Exocytosis, DNA-binding protein and Cancer cell. Her Receptor tyrosine kinase research includes elements of ROR1, Tropomyosin receptor kinase C and Mitogen-activated protein kinase. Her Growth factor receptor study incorporates themes from Insulin-like growth factor 1 receptor and ERBB3.

Her most cited work include:

  • Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. (669 citations)
  • C-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function (573 citations)
  • Mechanism of biological synergy between cellular Src and epidermal growth factor receptor (425 citations)

What are the main themes of her work throughout her whole career to date?

Cancer research, Proto-oncogene tyrosine-protein kinase Src, Cell biology, Phosphorylation and Tyrosine kinase are her primary areas of study. Her Cancer research research includes themes of Endocrinology, Carcinogenesis, Internal medicine, LNCaP and Growth factor receptor. Her studies deal with areas such as ERBB3, Epidermal growth factor receptor and Tyrosine phosphorylation as well as Proto-oncogene tyrosine-protein kinase Src.

While the research belongs to areas of Cell biology, Sarah J. Parsons spends her time largely on the problem of Cytokinesis, intersecting her research to questions surrounding Guanine nucleotide exchange factor. Her Phosphorylation research incorporates themes from Receptor, Epidermal growth factor, Tyrosine, Molecular biology and Kinase. Her study in Tyrosine kinase is interdisciplinary in nature, drawing from both Receptor tyrosine kinase, Estrogen receptor and Transfection.

She most often published in these fields:

  • Cancer research (43.01%)
  • Proto-oncogene tyrosine-protein kinase Src (40.86%)
  • Cell biology (36.56%)

What were the highlights of her more recent work (between 2010-2019)?

  • Cell biology (36.56%)
  • Cancer research (43.01%)
  • Prostate cancer (10.75%)

In recent papers she was focusing on the following fields of study:

Sarah J. Parsons focuses on Cell biology, Cancer research, Prostate cancer, Internal medicine and Androgen receptor. Her study of Phosphorylation is a part of Cell biology. Her Cancer research study integrates concerns from other disciplines, such as Tyrosine and Protein kinase A.

Her work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Oncology. Her research in Endocrinology intersects with topics in Tyrosine kinase, Estrogen receptor beta, Receptor tyrosine kinase and Estrogen receptor alpha. Her Integrin research also works with subjects such as

  • Endosome and related Kinase,
  • Protein kinase R that intertwine with fields like Proto-oncogene tyrosine-protein kinase Src.

Between 2010 and 2019, her most popular works were:

  • microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma (80 citations)
  • Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells (62 citations)
  • Inhibition of Neurotensin Receptor 1 Selectively Sensitizes Prostate Cancer to Ionizing Radiation (37 citations)

In her most recent research, the most cited papers focused on:

  • Enzyme
  • Cancer
  • Apoptosis

Her main research concerns Cell biology, Prostate cancer, Androgen receptor, Cell growth and Neurosphere. In the field of Cell biology, her study on Focal adhesion, Proto-oncogene tyrosine-protein kinase Src and Protein kinase R overlaps with subjects such as ULK1. Sarah J. Parsons combines subjects such as Signal transduction, Protein tyrosine phosphatase, Apoptosis, Annexin and Molecular biology with her study of Prostate cancer.

The study incorporates disciplines such as 2-Methoxyestradiol, Gene knockdown, Mdm2 and Small interfering RNA in addition to Androgen receptor. Sarah J. Parsons interconnects Oncomir, Stem cell and Apoptosis Regulator in the investigation of issues within Cell growth.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.

Roy Garcia;Tammy L Bowman;Guilian Niu;Hua Yu.
Oncogene (2001)

947 Citations

C-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function

Jacqueline S. Biscardi;Ming Chei Maa;David A. Tice;Michael E. Cox.
Journal of Biological Chemistry (1999)

773 Citations

Mechanism of biological synergy between cellular Src and epidermal growth factor receptor

David A. Tice;Jacqueline S. Biscardi;Amanda L. Nickles;Sarah J. Parsons.
Proceedings of the National Academy of Sciences of the United States of America (1999)

658 Citations

Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways

J Thomas Parsons;Sarah J Parsons.
Current Opinion in Cell Biology (1997)

550 Citations

Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers.

Ming Chei Maa;Tzeng Horng Leu;Deborah J. Mccarley;Randall C. Schatzman.
Proceedings of the National Academy of Sciences of the United States of America (1995)

437 Citations

Tyrosine kinase signalling in breast cancer: Epidermal growth factor receptor and c-Src interactions in breast cancer

Jacqueline S Biscardi;Rumey C Ishizawar;Corinne M Silva;Sarah J Parsons.
Breast Cancer Research (2000)

420 Citations

c-Src, receptor tyrosine kinases, and human cancer.

Jacqueline S. Biscardi;David A. Tice;Sarah J. Parsons.
Advances in Cancer Research (1999)

366 Citations

c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation.

Jin-Hong Chang;Satinder Gill;Jeffrey Settleman;Sarah J. Parsons.
Journal of Cell Biology (1995)

362 Citations

Phosphorylation of Y845 on the Epidermal Growth Factor Receptor Mediates Binding to the Mitochondrial Protein Cytochrome c Oxidase Subunit II

Julie L. Boerner;Michelle L. Demory;Corinne Silva;Sarah J. Parsons.
Molecular and Cellular Biology (2004)

271 Citations

Acquisition of Neuroendocrine Characteristics by Prostate Tumor Cells Is Reversible: Implications for Prostate Cancer Progression

Michael E. Cox;Paul D. Deeble;Saquib Lakhani;Sarah J. Parsons.
Cancer Research (1999)

256 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sarah J. Parsons

Richard Jove

Richard Jove

Nova Southeastern University

Publications: 45

Carl E. Creutz

Carl E. Creutz

University of Virginia

Publications: 25

Jennifer R. Grandis

Jennifer R. Grandis

University of California, San Francisco

Publications: 22

Jeffrey Settleman

Jeffrey Settleman

Pfizer (Germany)

Publications: 20

Mien Chie Hung

Mien Chie Hung

China Medical University

Publications: 18

Hsing Jien Kung

Hsing Jien Kung

Taipei Medical University

Publications: 18

Robert Ian Nicholson

Robert Ian Nicholson

Cardiff University

Publications: 17

Gary E. Gallick

Gary E. Gallick

The University of Texas MD Anderson Cancer Center

Publications: 17

Enrique Rozengurt

Enrique Rozengurt

University of California, Los Angeles

Publications: 17

Hua Yu

Hua Yu

City Of Hope National Medical Center

Publications: 17

Martin E. Gleave

Martin E. Gleave

University of British Columbia

Publications: 17

Maik Hüttemann

Maik Hüttemann

Wayne State University

Publications: 16

Gautam Sethi

Gautam Sethi

National University of Singapore

Publications: 16

James M. Samet

James M. Samet

Environmental Protection Agency

Publications: 14

Michael J. Weber

Michael J. Weber

University of Virginia

Publications: 14

Gordon B. Mills

Gordon B. Mills

Oregon Health & Science University

Publications: 14

Trending Scientists

Hai Zhuge

Hai Zhuge

Chinese Academy of Sciences

Emmanuel Thanassoulis

Emmanuel Thanassoulis

Aston University

Thomas Kneib

Thomas Kneib

University of Göttingen

MK Meint Smit

MK Meint Smit

Eindhoven University of Technology

Peter K. Kitanidis

Peter K. Kitanidis

Stanford University

Mihail Barboiu

Mihail Barboiu

University of Montpellier

Siegfried Hünig

Siegfried Hünig

University of Würzburg

Juan Colmenero

Juan Colmenero

University of the Basque Country

Per I. Arvidsson

Per I. Arvidsson

Science for Life Laboratory

Paul R. Raithby

Paul R. Raithby

University of Bath

James B. Whitfield

James B. Whitfield

University of Illinois at Urbana-Champaign

J.B. van Wyk

J.B. van Wyk

University of the Free State

Kenneth Maiese

Kenneth Maiese

Wayne State University

Riccardo Russo

Riccardo Russo

University of Essex

Tzong-Hae Lee

Tzong-Hae Lee

Blood Systems Research Institute

Vincenzo Bronte

Vincenzo Bronte

University of Verona

Something went wrong. Please try again later.